LOREA _ ANALYSIS OF THE EFFECTIVENESS AND SAFETY OF LORLATINIB IN UNTREATED ALK-POSITIVE NSCLC PATIENTS IN A FRENCH REAL-WORLD CONTEXT First published 01/07/2026 Last updated 01/07/2026 EU PAS number:EUPAS1000000111 Study Ongoing